Periscope Capital’s Peak Bio, Inc. Warrant PKBOW Stock Holding History

Periscope Capital’s Portfolio PKBOW Stock Details PKBOW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-75,000	Closed	-$6K	–	973
2022 Q3	$6K	Hold	75,000	–	–	﹤0.01%	1067
2022 Q2	$13K	Hold	75,000	–	–	﹤0.01%	1060
2022 Q1	$32K	Hold	75,000	–	–	﹤0.01%	1049
2021 Q4	$61K	Hold	75,000	–	–	﹤0.01%	901
2021 Q3	$48K	Hold	75,000	–	–	﹤0.01%	844
2021 Q2	$74K	Hold	75,000	–	–	﹤0.01%	707
2021 Q1	$67K	Buy	+75,000	New	+$84.5K	﹤0.01%	531

Other funds holding PKBOW

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

EFI

EHP Funds Inc Toronto, Canada $43.6M AUM 69.08% 1-Year Est. Return

WAM

Warberg Asset Management Winnetka, Illinois $600M AUM 23.37% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

SCM

Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

YCM

Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return

CCM

Context Capital Management Lajolla, California $4.33B AUM 1.35% 1-Year Est. Return

FTUS

Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

Periscope Capital's PKBOW Position: Q4 2022 in Review

Periscope Capital sold out of Peak Bio, Inc. Warrant (PKBOW) in Q4 2022, closing a stake of 75,000 shares — an estimated $6K sold.

Periscope Capital first reported a position in PKBOW in Q1 2021 and held it in 7 quarters. The position peaked at $74K in Q2 2021. 15 funds tracked by Wall St. Rank hold PKBOW as of Q4 2022.

Periscope Capital reported no remaining Peak Bio, Inc. Warrant position as of Q4 2022 after selling out during the quarter.
Periscope Capital sold 75,000 Peak Bio, Inc. Warrant shares in Q4 2022, an estimated $6K.
Periscope Capital first reported a position in Peak Bio, Inc. Warrant in Q1 2021 and held it in 7 quarters.
Periscope Capital's Peak Bio, Inc. Warrant position peaked at $74K in Q2 2021.
15 funds tracked by Wall St. Rank held Peak Bio, Inc. Warrant as of Q4 2022.

Based on Periscope Capital's 13F filing for Q4 2022, filed 13 Feb 2023.